Corcept Therapeutics, Inc. (CORT)
56.37
-1.93
(-3.31%)
USD |
NASDAQ |
May 15, 16:00
56.40
+0.02
(+0.04%)
After-Hours: 20:00
Corcept Therapeutics EPS Diluted (Quarterly) : -0.2988 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Supernus Pharmaceuticals, Inc. | -0.0398 |
| Terns Pharmaceuticals, Inc. (DELISTED) | -0.2395 |
| Assertio Holdings, Inc. | -2.931 |
| Nektar Therapeutics | -1.815 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.20M |
| Revenue (Quarterly) | 164.90M |
| Total Expenses (Quarterly) | 196.10M |
| Enterprise Value | 5.723B |
| Gross Profit Margin (Quarterly) | 98.25% |
| Profit Margin (Quarterly) | -18.92% |
| Earnings Yield | 0.62% |
| Normalized Earnings Yield | 0.6209 |